FANHDI 100 IUML (FACTOR VIII) इसराइल - अंग्रेज़ी - Ministry of Health

fanhdi 100 iuml (factor viii)

medici medical ltd, israel - factor viii (human) - powder for solution for injection - factor viii (human) 1000 iu - coagulation factor viii - coagulation factor viii - is indicated for the prevention and control of bleeding in patients with moderate or severe factor viii deficiency due to classical hemophilia a . fanhdi is not effective in controlling the bleeding of patients with von willebrond's disease.

HAEMOCTIN SDH 250 IU इसराइल - अंग्रेज़ी - Ministry of Health

haemoctin sdh 250 iu

kamada ltd, israel - human plasma coagulation factor viii - powder for solution for injection - human plasma coagulation factor viii 50 iu/ml - coagulation factor viii - coagulation factor viii - treatment and prophylaxis of bleeding: in patients with haemophilia a (congenital factor viii deficiency) in patient with acquired factor viii deficiency. haemoctin is not effective in controlling the bleeding of patients with von willebrond`s disease.

HAEMOCTIN SDH 500 IU इसराइल - अंग्रेज़ी - Ministry of Health

haemoctin sdh 500 iu

kamada ltd, israel - human plasma coagulation factor viii - powder and solvent for solution for injection - human plasma coagulation factor viii 50 iu/ml - coagulation factor viii - coagulation factor viii - treatment and prophylaxis of bleeding: in patients with haemophilia a (congenital factor viii deficiency) in patient with acquired factor viii deficiency.haemoctin is not effective in controlling the bleeding of patients with von willebrond`s disease.

HAEMOCTIN SDH 1000 IU इसराइल - अंग्रेज़ी - Ministry of Health

haemoctin sdh 1000 iu

kamada ltd, israel - human plasma coagulation factor viii - powder and solvent for solution for injection - human plasma coagulation factor viii 100 iu/ml - coagulation factor viii - coagulation factor viii - treatment and prophylaxis of bleeding: in patients with haemophilia a (congenital factor viii deficiency) in patient with acquired factor viii deficiency.haemoctin is not effective in controlling the bleeding of patients with von willebrond`s disease.

ADVATE 500 IU इसराइल - अंग्रेज़ी - Ministry of Health

advate 500 iu

takeda israel ltd - octocog alfa (antihemophilic factor recombinant) - powder for solution for injection - octocog alfa (antihemophilic factor recombinant) 500 iu/vial - coagulation factor viii - coagulation factor viii - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency).

ADVATE 1000 IU इसराइल - अंग्रेज़ी - Ministry of Health

advate 1000 iu

takeda israel ltd - octocog alfa (antihemophilic factor recombinant) - powder for solution for injection - octocog alfa (antihemophilic factor recombinant) 1000 iu/vial - coagulation factor viii - coagulation factor viii - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency).

ADVATE 1500 IU इसराइल - अंग्रेज़ी - Ministry of Health

advate 1500 iu

takeda israel ltd - octocog alfa (antihemophilic factor recombinant) - powder for solution for injection - octocog alfa (antihemophilic factor recombinant) 1500 iu/vial - coagulation factor viii - coagulation factor viii - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency).

ADVATE 2000 IU इसराइल - अंग्रेज़ी - Ministry of Health

advate 2000 iu

takeda israel ltd - octocog alfa (antihemophilic factor recombinant) - powder for solution for injection - octocog alfa (antihemophilic factor recombinant) 2000 iu/vial - coagulation factor viii - coagulation factor viii - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency).

ADVATE 3000 IU इसराइल - अंग्रेज़ी - Ministry of Health

advate 3000 iu

takeda israel ltd - octocog alfa (antihemophilic factor recombinant) - powder for solution for injection - octocog alfa (antihemophilic factor recombinant) 3000 iu/vial - coagulation factor viii - coagulation factor viii - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency).

OCTANATE 250 International Unit Pdr+Solv for Soln for Inj आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

octanate 250 international unit pdr+solv for soln for inj

octapharma limited - human plasmafraktion (factor viii) - pdr+solv for soln for inj - 250 international unit - blood coagulation factors